Interviews

Dr. Shalabh Gupta, CEO of Unicycive Therapeutics, discusses the company's focus on kidney care and its lead drug candidate for…

Chris Ehrlich, CEO of CERo Therapeutics, discusses the company's novel approach to cancer immunotherapy and its CER-T platform. On Technology…

Dr. Manoj Agarwal, CEO of Kairos Pharma, shares insights on the company's oncology pipeline and development strategy. On Pipeline Priorities…

Danny Yeung, CEO of Prenetics, discusses the evolution of consumer genetic testing and the company's growth strategy. On Market Evolution…

Kimball Carr, CEO of Inspire Veterinary Partners, discusses the veterinary practice consolidation opportunity and the company's growth strategy. On Industry…

Marc Belsky, CEO of Plus Therapeutics, discusses advances in radiopharmaceutical treatments for cancer. On Technology Q: Can you explain Plus…

Paul Romness, CEO of OS Therapies, discusses the company's commitment to developing treatments for osteosarcoma. On Unmet Need Q: Why…

Daniel Wagner, CEO of Rezolve Ai, discusses how artificial intelligence is transforming commerce experiences. On AI Applications Q: How is…

Lewis Bender, CEO of Intensity Therapeutics, discusses the company's intratumoral drug delivery approach. On Technology Platform Q: Can you explain…

Zheng Zhong, CEO of Richtech Robotics, discusses the growing adoption of service robots across industries. On Market Trends Q: What…